Argitalpenak (171) NICOLÁS MENDOZA LADRÓN DE GUEVARA argitalpenak

2024

  1. EMAS position statement: Thyroid disease and menopause

    Maturitas, Vol. 185

  2. Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis

    Menopause (New York, N.Y.), Vol. 31, Núm. 3, pp. 234-242

  3. Exercise for peri- and postmenopausal women: Recommendations from synergistic alliances of women's medicine and health psychology for the promotion of an active lifestyle

    Maturitas, Vol. 185

  4. Impact of violence against women on quality of life and menopause-related disorders

    Maturitas, Vol. 180

2023

  1. A reliable and valid tool to assess the sexual acceptability of contraceptive methods

    Frontiers in public health, Vol. 11, pp. 1302675

  2. Associations between Menopausal Hormone Therapy and Colorectal, Lung, or Melanoma Cancer Recurrence and Mortality: A Narrative Review

    Journal of Clinical Medicine, Vol. 12, Núm. 16

  3. EMAS position statement: Testosterone replacement therapy in older men

    Maturitas, Vol. 178

  4. EMAS position statement: Vitamin D and menopausal health

    Maturitas, Vol. 169, pp. 2-9

  5. Mediterranean diet for cancer prevention and survivorship

    Maturitas, Vol. 178

  6. Population-based survey on menopausal symptoms and treatment use

    Climacteric, Vol. 26, Núm. 1, pp. 47-54

  7. Sexuality in Postmenopausal Women with Genital Prolapse

    Journal of Clinical Medicine, Vol. 12, Núm. 19

  8. The AHAWOMEN project: study protocol of a multi-design research for exploring HAPA predictors of exercise in postmenopausal women

    BMC Psychology, Vol. 11, Núm. 1

  9. Treatment of Female Sexual Dysfunction Due to Dyspareunia with Solid-State Vaginal Laser and Recombinant Platelet-Derived Epidermal Growth Factors: A Viable Possibility?

    Clinical and Experimental Obstetrics and Gynecology, Vol. 50, Núm. 2

2022

  1. Application of a new ultrasound criterion for the diagnosis of polycystic ovary syndrome

    Frontiers in Endocrinology, Vol. 13

  2. Double HCG trigger improves recovery of oocytes in women with a paucifollicular response to ovarian stimulation: A pilot study

    International Journal of Gynecology and Obstetrics, Vol. 157, Núm. 1, pp. 149-153

  3. Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group

    Maturitas, Vol. 166, pp. 65-85

  4. Hiperandrogenismos distintos del síndrome de ovario poliquístico

    Obstetricia y ginecología (Elsevier), pp. 324-327

  5. Impact of Violence against Women on Sexual and Reproductive Health: Research Protocol and Results from a Pilot Study

    Clinical and Experimental Obstetrics and Gynecology, Vol. 49, Núm. 7

  6. Managing vulvar and vestibular pain in postmenopausal women: recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia, Sociedad Española de Medicos de Atención Primaria y Federación Española de Sociedades de Sexología

    Gynecological Endocrinology, Vol. 38, Núm. 3, pp. 263-266

  7. Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society

    Maturitas, Vol. 163, pp. 1-14